Nexvet Biopharma plc (NASDAQ:NVET) Posted Basic Consolidated EPS Of $-1.6814

0

Nexvet Biopharma plc (NASDAQ:NVET) annual basic consolidated EPS was $-1.6814 for the period ended 2016-06-30. The basic consolidated EPS was $-1.6814 for the quarter ended 2016-06-30.

EPS from continuing operations

Nexvet Biopharma plc (NASDAQ:NVET)’s basic EPS from continuing operations was $-1.6814 for the fiscal year 2016-06-30. For the quarter ended 2016-06-30 it stood at $-1.6814

EPS contribution from parent

From the parent company Nexvet Biopharma plc (NASDAQ:NVET) posted basic EPS of $-1.6814 for the fiscal ended 2016-06-30. For the quarter that ended on 2016-06-30 the figure stood at $-1.6814.

Basic net EPS

The Basic net EPS of Nexvet Biopharma plc (NASDAQ:NVET) was $-1.68 for the period ended 2016-06-30. The figure stood at $-1.68 for the quarter that ended 2016-06-30.

Consolidated diluted EPS

The consolidated diluted EPS for the fiscal year 2016-06-30 stood at $-1.6814. While the figure for the quarter ended 2016-06-30 stood at $-1.6814.

Basic diluted EPS

The diluted EPS from continuing operation of Nexvet Biopharma plc (NASDAQ:NVET) stood at $-1.6814 for the fiscal 2016-06-30. The figure for the quarter ended 2016-06-30 stood at $-1.6814

Net diluted EPS

The Net diluted EPS was $-1.68 for the fiscal 2016-06-30. The figure for the quarter ended 2016-06-30 stood at $-1.68.

Diluted EPS from parent

Nexvet Biopharma plc (NASDAQ:NVET) diluted EPS from the parent company for the fiscal 2016-06-30 was $-1.6814. The figure for the quarter ended 2016-06-30 was $-1.6814

The net basic EPS was $-1.68 for fiscal 2016-06-30. The figure for the quarter ended 2016-06-30 was $-1.68

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 13 times, 1 visits today)